This is a multi-centre and multinational basket study that will monitor the long-term safety and tolerability of cell or gene therapies in participants that have taken part in other AstraZeneca cell or gene therapy studies for up to 15 years.
Age
18–130
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. The participant has received a cell or gene therapy in another AstraZeneca protocol.
2. Provision of signed and dated, written informed consent before any study-specific procedures.
You may not be if
Not applicable
\-
Clareo Health | LTFU for All Cell and Gene Therapy Studies
